Bayer HealthCare Pharmaceuticals Provides Euro 250.000 Grant to the World Federation of Hemophilia to Support Innovative Patient Care Research and Educational Initiatives

BERKELEY, Calif., April 16 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that it has awarded euro 250.000 to the World Federation of Hemophilia (WFH) to support groundbreaking initiatives that aim to improve the overall state of hemophilia care for patients around the world. Over the past three years, Bayer has provided WFH with euro 750.000 as part of the company's steadfast commitment to improving the quality of care for people living with hemophilia.